Jeffrey Adelglass - Concepedia

Author

Jeffrey Adelglass

Also Known As

Erika Mendoza, J ADELGLASS, J. Adelglass, Jeffrey Adelglass, Jeffrey M Adelglass, Jeffrey M. Adelglass, Michael Adams, Robert S. Haber

Publications

986

Citations

H-Index

Concepts

All Affiliations

Novavax (United States)University of North Carolina at Chapel Hill University of Maryland, Baltimore Fred Hutch Cancer Center National Institute of Allergy and Infectious Diseases

About

Jeffrey Adelglass is an author at Novavax (United States) specializing in medicine, sinusitis, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	297
2	Allergy	2	2	68
3	Health Sciences	1	1	52
4	Allergy Medicine	1	1	56
5	Epidemiology	1	1	37

Jeffrey Adelglass

Publications

918

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay, New England Journal of Medicine	2021	445
Comparison of the Effectiveness of Levofloxacin and Amoxicillin‐Clavulanate for the Treatment of Acute Sinusitis in Adults Jeffrey Adelglass, C. Andrew DeAbate, Phillip McElvaine, Otolaryngology Abdominal PainAntimicrobial StewardshipAntibioticsAcute SinusitisPharmacology	1999	59
Dose Ranging Study of Mometasone Furoate (Nasonex) in Seasonal Allergic Rhinitis Edwin A. Bronsky, Donald W. Aaronson, Robert Berkowitz, Annals of Allergy Asthma & Immunology AsthmaDose Ranging StudyAllergyAllergy MedicineSeasonal Allergic Rhinitis	1997	56
A Multicenter, Investigator‐Blinded, Randomized Comparison of Oral Levofloxacin and Oral Clarithromycin in the Treatment of Acute Bacterial Sinusitis Jeffrey Adelglass, Terry M. Jones, Gary Ruoff, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy Clarithromycin GroupClarithromycin 500Acute Bacterial SinusitisHealth SciencesAntibiotics	1998	52
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents Germán Áñez, Lisa M. Dunkle, Cynthia L. Gay, JAMA Network Open	2023	48
Calcium Hydroxylapatite Dermal Filler for Treatment of Dorsal Hand Volume Loss: Results From a 12-Month, Multicenter, Randomized, Blinded Trial Mitchel P. Goldman, Amir Moradi, Michael H. Gold, Dermatologic Surgery	2017	47
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial Heather Platt, Christopher Bruno, Erik Buntinx, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentInternational Phase 3Immunology	2024	41
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay, Placebo-controlled TrialUnited StatesCovid-19Influenza VaccinesPreventive Medicine	2021	37
Lidocaine/tetracaine peel in topical anesthesia prior to laser-assisted hair removal: Phase-II and Phase-III study results Tina S. Alster, Jerome M. Garden, Richard Fitzpatrick, Journal of Dermatological Treatment	2012	21
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis Dan Henry, Daniel Möller, Jeffrey Adelglass, Clinical Therapeutics MedicineSinusitisAntibiotics	1999	20

Page 1